Blood esinophils, FeNO, and the modifiable risk of asthma attacks

Recorded webinar

In Sanofi’s RespTalks webinar in January, Professor Ian Pavord & Dr. Simon Couillard discussed the concept of treatable traits as a new approach to managing asthma. In this recording, we hear Dr. Couillard presenting his views on how the treatable traits approach can aid the management of severe asthma.

Speaker: Simon Couillard, MD

Simon Couillard, MD, is a Canadian specialist in respiratory medicine and a clinical teacher at the Université de Sherbooke. He finished a two-year clinical research fellowship in severe asthma with the University of Oxford under the supervision of Professor Pavord, and has started a joint Oxford-Leiden PhD on risk prediction in asthma.

Previously broadcast RespTalks

Resptalks is a series of scientific webinars & podcasts on current topics related to respiratory diseases such as asthma, chronic rhinosinusitis with nasal polyps, to type 2 inflammation and much more.

Watch previous recordings

*Lees verplichte informatie over Dupixent